hydrazine has been researched along with Recrudescence in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (17.86) | 29.6817 |
| 2010's | 12 (42.86) | 24.3611 |
| 2020's | 8 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Chalopin, T; Nsiala, L | 1 |
| Calvo, KR; Desmond, R; Dunbar, CE; Fan, X; Groarke, EM; Larochelle, A; Patel, B; Winkler, T; Young, DJ; Young, NS | 1 |
| Chen, N; Hamzeh, I; Kamran, H; Mims, M; Sudhakar, D | 1 |
| Amberg, S; Bokemeyer, C; Christine Wilke, A; Chromik, J; Deppermann, U; Fiedler, W; Ganser, A; Heuser, M; Janning, M; Kebenko, M; Kranich, AL; Modemann, F; Schlipfenbacher, V; Serve, H; Theile, S; Thol, F | 1 |
| Chen, M; Han, B; Ruan, J; Yang, C; Zuo, W | 1 |
| DeMari, S; Hassan, H; Hughes, DM; Sanchorawala, V; Sloan, JM | 1 |
| Bradbury, C; Cooper, N; Grainger, J; Hill, QA; Provan, D; Ramscar, N; Roy, A; Thachil, J; Westwood, JP | 1 |
| Abid, H; Abid, MB; Wu, JF | 1 |
| Chan, TSY; Cheung, CYM; Gill, H; Hwang, YY; Kwong, YL; Leung, GMK | 1 |
| Scheinberg, P | 1 |
| Chari, A; Cole, CE; Hycner, T; Jakubowiak, AJ; Jasielec, JK; Karrison, T; McIver, A; Mikhael, J; Nam, J; Rosebeck, S; Rosenbaum, CA; Severson, E; Stephens, LA; Tinari, K; Turowski, A; Zimmerman, TM; Zonder, JA | 1 |
| Amaddii, G; Billio, A; Cortelazzo, S; Natolino, F; Piccin, A | 1 |
| Bryan, J; Kadia, TM; Rexwinkle, A; Willis, L | 1 |
| Aguilar, C; Alonso, A; Alonso, R; Álvarez-Román, MT; Andrade, MM; Arratibel, MC; Beneit, P; Bernat, S; Calbacho, M; Caparrós, I; Casaus, A; Coria, E; Cortés, M; Cortti, MJ; de Cabo, E; de Cos, C; Fernández-Canal, C; Fernández-Fuertes, F; Fernández-Miñano, C; Fernández-Rodríguez, A; Fisac, R; Fuertes-Palacio, MA; Galán, P; Garcia-Frade, J; Gómez-Núñez, M; González-López, TJ; González-Porras, JR; González-Silva, M; Gutierrez-Jomarrón, I; Hernández-Rivas, JA; Jarque, I; Jiménez, R; Luaña, A; Martín-Salces, M; Martínez-Robles, V; Mingot-Castellano, ME; Olivera, PE; Pascual, C; Paz Martínez-Badas, M; Peñarrubia, MJ; Perera, M; Pérez-Crespo, S; Pérez-Rus, G; Sainz, A; Sánchez-González, B; Solán, L; Valcarce, I; Vázquez-Paganini, JA | 1 |
| Desmond, R; Dunbar, C; Townsley, DM; Young, NS | 1 |
| Abdul Razak, AR; Bartha-Vári, JH; Boros, Z; Cai, S; Carlson, R; Chong, YS; Chua, SY; Dagis, A; Feng, X; Foo, VH; Gabrail, NY; Gerecitano, JF; Gluckman, P; Huber, S; Ikram, MK; Irimie, FD; Kauffman, M; Kim, R; Kwek, K; Landesman, Y; Lassen, U; Li, D; Li, Q; Liu, C; Ma, J; Mahipal, A; Mau-Soerensen, M; McCauley, D; Mirza, MR; Nademanee, A; Ngo, C; Paizs, C; Palmer, JM; Pizzari, T; Poppe, L; Rashal, T; Saint-Martin, JR; Saw, SM; Shacham, S; Shields, AF; Stayner, LA; Tan, CS; Thorborg, K; Toşa, MI; Tsai, NC; Unger, TJ; Verkicharla, PK; Vértessy, BG; Wang, S; Wang, Y; Weiser, D; Wollin, M; Wong, TY; Xu, L; Yuan, L; Yuan, S; Zhang, Y; Zheng, R | 1 |
| Albitar, M; Boskovic, D; Brandwein, J; Cahill, A; DeAngelo, D; Giles, F; Kell, J; O'Brien, S; Pigneux, A; Robak, T; Seiter, K; Staib, P; Stock, W; Stuart, R; Tallman, M; Thomas, X; Vey, N | 1 |
| Chen, H; Deisseroth, A; Farrell, A; He, K; Justice, R; Kane, R; Pazdur, R; Sridhara, R | 1 |
| Giagounidis, A; Greinacher, A; Hiller, E; Kiefel, V; Matzdorff, A; Müller-Beissenhirtz, H; Ostermann, H; Rummel, M; Sachs, UJ; Salama, A | 1 |
| Frederiksen, H; Gudbrandsdottir, S; Hasselbalch, H | 1 |
| Biancotto, A; Calvo, KR; Desmond, R; Dumitriu, B; Dunbar, CE; Feng, X; Lozier, J; Olnes, MJ; Parikh, AR; Scheinberg, P; Soto, S; Tang, Y; Wu, CO; Young, NS | 1 |
| Gómez, FM; Prieto, M; Teresa Giralt, M | 1 |
| Albitar, M; Bilgrami, SF; Cahill, A; Cooper, M; Daenen, S; Faderl, S; Feldman, E; Ferrant, A; Giles, F; Kantarjian, H; Karp, J; Karsten, V; Khan, KD; O'Brien, S; Roboz, G; Verstovsek, S; Vey, N | 1 |
| Arning, M; Bussel, JB; Cheng, G; Hassani, H; Jenkins, JM; Kloczko, J; Kovaleva, L; Mayer, B; Meddeb, B; Provan, D; Psaila, B; Saleh, MN; Stone, NL | 1 |
| Craig, CM; Schiller, GJ | 1 |
| Corsini, GU; Mangoni, A; Marrosu, F; Spissu, A | 1 |
| Ashton, JH; Buja, LM; Glas-Greenwalt, P; Golino, P; McNatt, J; O'Brien, RA; Willerson, JT; Yao, SK | 1 |
| Ashton, JH; Buja, LM; Glas-Greenwalt, P; Golino, P; McNatt, J; Willerson, JT | 1 |
5 review(s) available for hydrazine and Recrudescence
| Article | Year |
|---|---|
Risk for infections with selinexor in patients with relapsed/refractory multiple myeloma: a systematic review of clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Humans; Hydrazines; Infections; Multiple Myeloma; Recurrence; Triazoles | 2021 |
Recent Advances and Long-Term Results of Medical Treatment of Acquired Aplastic Anemia: Are Patients Cured?
Topics: Alemtuzumab; Anemia, Aplastic; Animals; Antilymphocyte Serum; Benzoates; Cyclosporine; Humans; Hydrazines; Immunosuppression Therapy; Immunosuppressive Agents; Pyrazoles; Recurrence; Treatment Outcome | 2018 |
Recent developments in drug therapy for aplastic anemia.
Topics: Alemtuzumab; Anemia, Aplastic; Animals; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Benzoates; Clinical Trials as Topic; Cyclosporine; Daclizumab; Humans; Hydrazines; Immunoglobulin G; Immunosuppressive Agents; Pyrazoles; Recurrence; Salvage Therapy; Survival Rate | 2014 |
Eltrombopag in aplastic anemia.
Topics: Anemia, Aplastic; Animals; Benzoates; Hematopoiesis; Humans; Hydrazines; Pyrazoles; Recurrence; Risk Factors; Thrombopoietin | 2015 |
Acute myeloid leukemia in the elderly: conventional and novel treatment approaches.
Topics: Adenine Nucleotides; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Arabinonucleosides; Arsenic Trioxide; Arsenicals; Azacitidine; Clofarabine; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Idarubicin; Leukemia, Myeloid, Acute; Middle Aged; Oxides; Recurrence; Sulfonamides | 2008 |
7 trial(s) available for hydrazine and Recrudescence
| Article | Year |
|---|---|
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Idarubicin; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Progression-Free Survival; Recurrence; Salvage Therapy; Triazoles | 2020 |
Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytogenetic Analysis; Dexamethasone; Drug Resistance, Neoplasm; Female; Humans; Hydrazines; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Oligopeptides; Prognosis; Recurrence; Retreatment; Treatment Outcome; Triazoles | 2019 |
Topics: Active Transport, Cell Nucleus; Adolescent; Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Benzhydryl Compounds; Benzylamines; Biopsy; Blood Glucose; Blood Transfusion; Cholesterol, LDL; Combined Modality Therapy; Cyclams; Diabetes Mellitus, Type 2; Disease Progression; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Glucosides; Glycated Hemoglobin; Granulocyte Colony-Stimulating Factor; Hamstring Muscles; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans; Hydrazines; Immunohistochemistry; Insulin-Secreting Cells; Leg; Male; Middle Aged; Muscle Strength; Neoplasms; Peripheral Blood Stem Cell Transplantation; Range of Motion, Articular; Recurrence; Remission Induction; Research Design; Reverse Transcriptase Polymerase Chain Reaction; Soccer; Sodium-Glucose Transport Proteins; Sodium-Glucose Transporter 2 Inhibitors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Triazoles; Young Adult | 2015 |
Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapse.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Double-Blind Method; Female; Humans; Hydrazines; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction; Sulfonamides; Young Adult | 2009 |
Eltrombopag and improved hematopoiesis in refractory aplastic anemia.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Benzoates; Bone Marrow Cells; Chronic Disease; Drug Resistance; Female; Humans; Hydrazines; Male; Middle Aged; Pyrazoles; Recurrence; Young Adult | 2012 |
A phase II study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients with very high risk relapsed acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Humans; Hydrazines; Infusions, Intravenous; Leukemia, Myeloid; Male; Middle Aged; Recurrence; Remission Induction; Risk Factors; Sulfonamides; Survival Rate; Treatment Outcome | 2006 |
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzoates; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hemorrhage; Humans; Hydrazines; Male; Middle Aged; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Quality of Life; Receptors, Thrombopoietin; Recurrence; Thrombopoietin | 2007 |
16 other study(ies) available for hydrazine and Recrudescence
| Article | Year |
|---|---|
[New European approval: Selinexor for triple class refractory multiple myeloma].
Topics: Administration, Oral; ADP-ribosyl Cyclase 1; Antibodies, Monoclonal, Humanized; Clinical Trials, Phase II as Topic; Drug Resistance, Neoplasm; Europe; Humans; Hydrazines; Immunomodulating Agents; Membrane Glycoproteins; Multiple Myeloma; Proteasome Inhibitors; Recurrence; Triazoles | 2022 |
Long-term eltrombopag for bone marrow failure depletes iron.
Topics: Anemia, Aplastic; Benzoates; Ferritins; Humans; Hydrazines; Iron; Iron Overload; Pancytopenia; Pyrazoles; Recurrence; Thrombocytopenia | 2022 |
A Sticky Situation: Aortic Valve Thrombus in Patient with Antiphospholipid Antibody Syndrome and Immune Thrombocytopenia.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aortic Valve; Aortic Valve Stenosis; Benzoates; Bicuspid Aortic Valve Disease; Bioprosthesis; Chest Pain; Craniotomy; Echocardiography; Echocardiography, Three-Dimensional; Echocardiography, Transesophageal; Enoxaparin; Female; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hematoma, Subdural, Acute; Humans; Hydrazines; Immunologic Factors; Plasma Exchange; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Recurrence; Rituximab; Stroke Volume; Thrombosis; Ventricular Dysfunction, Left; Warfarin | 2020 |
Eltrombopag is effective in patients with relapse/refractory aplastic anemia-report from a single center in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Benzoates; China; Female; Follow-Up Studies; Hospitals, University; Humans; Hydrazines; Male; Middle Aged; Pyrazoles; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult | 2020 |
Safety, Tolerability, and Efficacy of Selinexor in a Patient With Relapsed Light Chain (AL) Amyloidosis.
Topics: Humans; Hydrazines; Immunoglobulin Light-chain Amyloidosis; Male; Middle Aged; Recurrence; Triazoles | 2021 |
Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel.
Topics: Benzoates; Humans; Hydrazines; Medication Adherence; Physicians; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Recurrence; Remission Induction; Retreatment; Self Report; Surveys and Questionnaires; Thrombopoietin | 2021 |
Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting.
Topics: Adult; Anemia, Aplastic; Benzoates; Biomarkers; Combined Modality Therapy; Disease Management; Drug Resistance; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Male; Pyrazoles; Recurrence; Thrombopoietin; Transplantation, Homologous; Treatment Outcome; Young Adult | 2018 |
Idiopathic thrombocytopenic purpura resistant to eltrombopag, but cured with romiplostim.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Anticonvulsants; Benzoates; Drug Interactions; Drug Resistance; Humans; Hydrazines; Immunoglobulins, Intravenous; Male; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Recurrence; Rituximab; Thrombopoietin | 2014 |
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.
Topics: Adult; Aged; Benzoates; Blood Platelets; Chronic Disease; Drug Administration Schedule; Drug Monitoring; Erythropoiesis; Female; Follow-Up Studies; Hematinics; Humans; Hydrazines; Male; Middle Aged; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Thrombopoietin; Recurrence; Remission Induction; Retrospective Studies; Splenectomy; Treatment Outcome | 2015 |
Toxicity of laromustine plus high-dose cytarabine in patients with relapsed acute myeloid leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Double-Blind Method; Female; Humans; Hydrazines; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction; Sulfonamides | 2010 |
[Diagnosis and therapy of autoimmune thrombocytopenia. Recommendations of a joint Expert Group of DGHO, DGTI, DTH].
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Benzoates; Blood Coagulation Tests; Blood Platelets; Blood Transfusion; Child; Cross-Sectional Studies; Diagnosis, Differential; Evidence-Based Medicine; Germany; Hemorrhage; Hospitalization; Humans; Hydrazines; Immunization, Passive; Immunosuppressive Agents; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Recurrence; Rituximab; Splenectomy; Thrombopoietin | 2010 |
Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Benzoates; Blood Platelets; Celiac Disease; Denmark; Female; HIV Infections; Humans; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Lupus Erythematosus, Systemic; Male; Middle Aged; Off-Label Use; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Recurrence; Retrospective Studies; Thrombocytopenia; Thrombopoietin | 2012 |
Effects of acute, repeated and chronic variable stress on in vivo tyrosine hydroxylase activity and on alpha(2)-adrenoceptor sensitivity in the rat brain.
Topics: Acute Disease; Adrenergic alpha-Agonists; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Chronic Disease; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hippocampus; Hydrazines; Hypothalamus; Male; Norepinephrine; Oxymetazoline; Pain; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Recurrence; Stress, Physiological; Tail; Time Factors; Tyrosine 3-Monooxygenase | 2003 |
Treatment of Sydenham's chorea with a combination of L-dopa and a peripheral dopa decarboxylase inhibitor.
Topics: Acute Disease; Adolescent; Carbidopa; Chorea; Drug Therapy, Combination; Homovanillic Acid; Humans; Hydrazines; Levodopa; Male; Recurrence | 1975 |
Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Coronary Disease; Coronary Thrombosis; Dogs; Drug Therapy, Combination; Ergolines; Fatty Acids, Unsaturated; Hydrazines; Myocardial Reperfusion; Platelet Aggregation; Recombinant Proteins; Recurrence; Serotonin; Serotonin Antagonists; Thromboxane A2; Time Factors; Tissue Plasminogen Activator | 1989 |
Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.
Topics: Animals; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Dogs; Fatty Acids, Unsaturated; Hydrazines; Ketanserin; Platelet Aggregation; Recombinant Proteins; Recurrence; Serotonin; Thromboxane A2; Tissue Plasminogen Activator | 1988 |